Platinum-Taxol non-cross resistance in epithelial ovarian cancer.

The aim of this study was to assess the clinical evidence for platinum-Taxol non-cross-resistance in patients with epithelial ovarian cancer. Unlike other studies, only patients who had demonstrably progressive disease on platinum therapy were analysed. Patients received 135-200 mg m-2 of Taxol over...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Gore, M. E., Preston, N., A'Hern, R. P., Hill, C., Mitchell, P., Chang, J., Nicolson, M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Nature Publishing Group 1995
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2033816/
https://ncbi.nlm.nih.gov/pubmed/7779729
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg